In tackling the global shortage of radiologists, Artificial Intelligence (AI) emerges as a game-changer, revolutionizing the field of healthcare worldwide. With countries like Japan, the UK, and India grappling with limited radiology resources, the integration of AI becomes imperative in delivering timely and accessible med...

Generic drugmaker Zydus Lifesciences Ltd has announced the launch of olaparib, a PARP inhibitor, under the brand name IBYRA in India. This move aims to provide advanced cancer treatment at a significantly lower price, making it accessible to a wider population.

In a groundbreaking move, the National Medical Commission (NMC) has recently revised the eligibility criteria for the National Eligibility cum Entrance Test Undergraduate (NEET-UG) for medical and dental courses. The new rule allows non-biology stud...

In recent years, pursuing a medical degree (MBBS) abroad has witnessed a significant surge among Indian students. Motivated by factors such as cost-effectiveness, less intense competition for seats, and exposure to...